UNSPSC 85814417: Introduction of monoclonal antibody into spinal canal, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into spinal canal, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0R30M

UNSPSC 85814417 Introduction of monoclonal antibody into spinal canal, percutaneous approach is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The recent solicitations tagged to this code do not reflect interventional neurology or intrathecal pharmaceutical administration; instead, they span virtual urgent care, general medical services, occupational health screenings, behavioral health and substance use treatment, medical examinations, nursing home operations, cancer screening, and wellness administration across multiple state and local jurisdictions.

The mismatch between code name and actual solicitation content suggests either misclassification in source tagging or limited use of this specific Commodity code in state and local procurement. No issuing bodies have posted recent opportunities for monoclonal antibody delivery, intrathecal injection services, or related procedural care under this code. The code shows little relevant recent activity for business development purposes in the state and local procurement space.